Bevacizumab plus capecitabine as maintenance treatment after initial treatment with bevacizumab plus XELOX in previously untreated metastatic colorectal cancer: Updated findings from a randomized, multicenter phase III trial - DANE, FAYSAL (AMER SOC CLINICAL ONCOLOGY, 2011)